Pharma Reviews: OrbiMed Asia invests $7.5 mln more in Vivimed Labs unit

... business growth and, increase the Company's profitability by organic and inorganic Growth opportunities,” added Saurabh Gurnurkar, Executive Director of Uquifa. Vivimed is a Pharmaceuticals and Specialty Chemicals company headquartered in Hyderabad, India. It has manufacturing plants in India, ...
Read more: OrbiMed Asia invests $7.5 mln more in Vivimed Labs unit

Pharma Reviews: India and the future of life sciences innovation

The Indian pharmaceutical industry is a world leader in bringing generic drugs to the market in a cost-effective way. Additionally, many Western pharmaceutical companies have established small-molecule development and manufacturing in India. More recently, Indian pharma companies have ...
Read more: India and the future of life sciences innovation

US FDA News: FDA permits marketing of device to treat diabetic foot ulcers

FDA permits marketing of device to treat diabetic foot ulcers
Read more: FDA permits marketing of device to treat diabetic foot ulcers

Pharma Reviews: Bank of Baroda buys out Pioneer Investments from AMC unit

It will acquire 51% of Baroda Pioneer Asset Management Company for an undisclosed amount. This is being done due to the acquisition of Pioneer Investments by Amundi, which already has India operations. The company said it will explore the option of bringing in another partner. A year ago ...
Read more: Bank of Baroda buys out Pioneer Investments from AMC unit

Pharma Reviews: Pharma 2018: Expect more M&As, USFDA reinspections in a normalised year

What is the outlook for Indian pharma in 2018? Analysts tend to think that it's a bit uncertain but many still feel the worst may be over. The last three fiscal years have been challenging for Indian pharma companies. The year 2015/16 saw price regulations being rung in by the pricing regulator. The next ...
Read more: Pharma 2018: Expect more M&As, USFDA reinspections in a normalised year

Pharma Reviews: Complex generics, domestic demand to help pharma weather regulated market de-growth

The Indian pharmaceutical industry will weather the current headwinds of slowdown in exports caused by regulatory scrutiny and intensifying competition, by monetising opportunities in complex products in the regulated markets, and because of resilient domestic demand, according to credit rating ...
Read more: Complex generics, domestic demand to help pharma weather regulated market de-growth

Pharma Reviews: Pharma 2019: Expect more M&As, USFDA re-inspections, a normalized year despite domestic ...

What is the outlook for the Indian pharma companies in 2019? Analysts tend to think while the outlook is a bit murky in India but still many feel the worst may be over with FY16 seeing price regulations from the price regulator, FY 17 seeing demonetization and FY 18 the impact of switchover to Goods and ...
Read more: Pharma 2019: Expect more M&As, USFDA re-inspections, a normalized year despite domestic ...

Pharma Reviews: Growth will return to pharma sector in 2018: V Srivatsa of UTI Mutual Fund

But since last year, the Indian pharma has specifically being impacted by demonetisation and to some extent GST. Also, in the last three years, there have been additional pricing control and more importantly there was a ban on some stores also which impacted certain companies. Having said that, we ...
Read more: Growth will return to pharma sector in 2018: V Srivatsa of UTI Mutual Fund

Pharma Reviews: Pharmaceutical stocks regain health as brokers turn bullish

Pharmaceutical stocks seem to have regained their health, as the stocks notched up gains of up 15% on Wednesday. Indian pharmaceutical market's (IPM) secondary sales continued to grow at a healthy rate in November, led by strong volume growth, said Motilal Oswal in a report. “After declining 0.5% ...
Read more: Pharmaceutical stocks regain health as brokers turn bullish

Pharma Reviews: 'Biosimilars need huge investments, longer timelines'

Kiran Mazumdar-Shaw, Chairperson and Managing Director, Biocon, is elated about not only her company's achievements as the first Indian biotech company to get a US FDA nod for a biosimilar drug but is more happy about India and its talent making a mark in the global arena to prove naysayers ...
Read more: 'Biosimilars need huge investments, longer timelines'

Pharma Reviews: Complex generics to help pharma weather regulated market de-growth: Crisil

CRISIL believes the Indian pharmaceutical industry will weather the current headwinds of slowdown in exports caused by regulatory scrutiny and intensifying competition, by monetising opportunities in complex products in the regulated markets, and because of resilient domestic demand. The sector's ...
Read more: Complex generics to help pharma weather regulated market de-growth: Crisil

Pharma Reviews: Complex generics, domestic demand to help pharma weather regulated market de-growth: CRISIL

Complex generics, domestic demand to help pharma weather regulated market de-growth: CRISIL ... CRISIL believes the Indian pharmaceutical industry will whether the current headwinds of slowdown in exports caused by regulatory scrutiny and intensifying competition, by monetizing opportunities in ...
Read more: Complex generics, domestic demand to help pharma weather regulated market de-growth: CRISIL

Pharma Reviews: Indian Pharma sector on a positive trajectory, to reach $20 billion mark: ASSOCHAM Study

New Delhi, Dec 27 (KNN) The Indian pharmaceutical exports are likely to touch 30 per cent compound annual growth rate (CAGR) and witness $20 billion in 2020 which is currently $16.5 billion, a study revealed. The study conducted by ASSOCHAM and UL India informed of the possible graph.
Read more: Indian Pharma sector on a positive trajectory, to reach $20 billion mark: ASSOCHAM Study

Pharma Reviews: See Nifty at 12K by Mar 2019; crude hitting $70, return of LTCG in Budget 2018 key concerns ...

If these were to go some sort of into chapter 11, or you could have seen the bottom of pharma companies as far as India is concerned because a lot of market share will be taken by our Indian pharma companies like the Suns and Lupins of the world. And plus, it could also signal some sort of a price ...
Read more: See Nifty at 12K by Mar 2019; crude hitting $70, return of LTCG in Budget 2018 key concerns ...

Pharma Reviews: Govt's medicare drive pinches pharma, pvt hospitals in 2017

By Munish Shekhavat and Ajay Tyagi New Delhi, Dec 27 (PTI) Indian pharmaceutical and healthcare sectors will step into the new year with lingering bitter after-effects of proactive measures of the government, which pulled out all the stops in 2017 for affordable medicare in the country. While the ...
Read more: Govt's medicare drive pinches pharma, pvt hospitals in 2017

Pharma Reviews: Govt's medicare drive pinches pharma, private hospitals in 2017

Indian pharmaceutical and healthcare sectors will step into the new year with lingering bitter after-effects of proactive measures of the government, which pulled out all the stops in 2017 for affordable medicare in the country. While the government's directive to doctors to prescribe only generic names ...
Read more: Govt's medicare drive pinches pharma, private hospitals in 2017

Pharma Reviews: Govt's medicare drive pinches pharma, pvt hospitals in 2017

While the government's directive to doctors to prescribe only generic names unsettled pharma companies, the NPPA's (National Pharmaceutical Pricing ... Summing up 2017, Indian Pharmaceutical Alliance (IPA) Secretary General D G Shah told PTI that the industry was never up against so many ...
Read more: Govt's medicare drive pinches pharma, pvt hospitals in 2017

Pharma Reviews: Pharmexcil gearing up for business tour to African markets from Feb 18-28 to tap unexplored ...

The Pharmaceutical Export Promotion Council of India (Pharmexcil) is planning to venture into African markets to explore export opportunities for Indian pharmaceutical products in the region of DCR Congo, Nigeria and Cote D'lvoir. As part of this, the council is gearing up for a business tour to these ...
Read more: Pharmexcil gearing up for business tour to African markets from Feb 18-28 to tap unexplored ...

US FDA News: Linezolid Injection by Auromedics Pharma: Voluntary Recall - Due to Presence White Particle Matter That Has Been Identified as Mold

AuroMedics Pharma is voluntarily recalling one lot of Linezolid Injection 600mg/300mL flexible bags, NDC 55150 -242 -51 batch CLZ160007 expiration August 2018 to the hospital level. This batch was distributed May 15 through August 14, 2017. The product was found to contain white particulate matter that has been identified as mold.
Read more: Linezolid Injection by Auromedics Pharma: Voluntary Recall - Due to Presence White Particle Matter That Has Been Identified as Mold

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. on efforts to support more efficient and effective food recalls

FDA discusses the steps taken to improve the recall process, the HHS OIG report on recalls, and new policies being considered.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. on efforts to support more efficient and effective food recalls

Pharma Reviews: Indian pharma industry to touch 20 billion us dollar mark by 2020; heres why its crucial

In a great news for India, while the country is already leading destination for medical tourism across the world, the pharma industry is now slated to touch usd 20 billion mark by 2020 year. This according to the ASSOCHAM study which puts the pharma industry in India currently at 16.5 usd billion worth.
Read more: Indian pharma industry to touch 20 billion us dollar mark by 2020; heres why its crucial

Pharma Reviews: India fast emerging as inventors' hub for drugs patent

Chandigarh, Dec 24 (ANI): India is fast emerging as an inventors' hub for patents for an assortment of drugs worldwide. Around 15 per cent of the total 1.3 lakh patents filed in India from 2013 to 2015 have been contributed by the indigenous pharmaceutical industry. India is ranked second only to the ...
Read more: India fast emerging as inventors' hub for drugs patent

Pharma Reviews: Code for pharma marketing practices may be enforced soon

The law ministry had also sought a clarification on whether the proposed Uniform Code of Pharmaceuticals Marketing Practices (UCPMP) was similar to the professional conduct, etiquette and ethics code of the Indian Medical Council, which doctors must follow in their relationship with pharmaceutical ...
Read more: Code for pharma marketing practices may be enforced soon

Pharma Reviews: Liberate pharmacy education from dual control: Pharmaceutical Congress

Chandigarh [India], Dec.24 (ANI): Arguing that pharmacy education courses are not technical programmes, the 69th Indian Pharmaceutical Congress (IPC) on Sunday passed a resolution that called on the Central Government to liberate all pharmacy courses from dual control of two agencies, the ...
Read more: Liberate pharmacy education from dual control: Pharmaceutical Congress

Pharma Jobs: Medical Coding Jobs For Lifescience/Paramedical Freshers

Company: Achievers Spot
Qualification: BDS, B.E/B.Tech, BAMS, BHMS, B.Pharm, B.Sc, M.E/M.Tech/MS, M.Pharm, Mphil, M.Sc
Experience: 0 to 0
Salary: 1.40 to 3.40
location: Chennai, Madurai
Ref: 21681440
Summary: Medical Coding is the process of conversion of text ....
Read more: Medical Coding Jobs For Lifescience/Paramedical Freshers

Pharma Reviews: A glorious kickstart to 69th Indian Pharma Congress at Chitkara University

Chandigarh , Dec 22 : 69th Indian Pharmaceutical Congress (IPC), a three day International Conference between December 22-24, 2017, kickstarted at Chitkara University, Punjab campus with a grand and glorious inaugural ceremony presided by V. P. Badnore, Hon'ble Governor of Punjab, Brahm ...
Read more: A glorious kickstart to 69th Indian Pharma Congress at Chitkara University

Pharma Reviews: Only pharmacists can stop fake drug menace: Punjab Governor

Chandigarh , Dec.22 : Inaugurating the three-day 69th Indian Pharmaceutical Congress (IPC) at the Chitkara University Campus here on Friday, ... "India is facing huge challenge of fake drug menace, and to minimise it, the pharmacists role is very important apart from regulatory agencies which are ...
Read more: Only pharmacists can stop fake drug menace: Punjab Governor

Pharma Reviews: US FDA Approval for Us Holds Bigger Promise: Kiran Mazumdar-Shaw's Biocon

Biocon's win raises hopes for other Indian pharma companies—some already sell biosimilars in India, including Dr Reddy's Laboratories, Torrent ... Biocon collaborated with Dutch company Mylan NV to develop its biosimilar Trastuzumab, which is sold as Herceptin by the current intellectual property ...
Read more: US FDA Approval for Us Holds Bigger Promise: Kiran Mazumdar-Shaw's Biocon

Pharma Reviews: Epygen Biotech eying Indian biosimilar market with 5 drugs under pipeline

By 2022 global biosimilar market will cross USD 60 billion mark. India has 20 per cent of world's population but it produces just one per cent of world's biologics. By 2022, Indian bio-pharmaceutical space will go up to US$ 5 billion from existing less than US$1 billion. To capitalize on growing biosimilar ...
Read more: Epygen Biotech eying Indian biosimilar market with 5 drugs under pipeline

Pharma Reviews: Hospitals line up higher rate option

Patients' interest groups questioned this logic, asserting that hospitals have no right to profit from the sales of medicines procured at deep discounts from pharmaceutical companies. "Private institutional buyers take maximum advantage of the high MRPs to reap big profits," the All India Drug Action ...
Read more: Hospitals line up higher rate option

US FDA News: FDA updates the label of Tasigna to reflect that certain patients with a type of leukemia may be eligible to stop treatment after sustained response

FDA updates the label of Tasigna to reflect that certain patients with a type of leukemia may be eligible to stop treatment after sustained response
Read more: FDA updates the label of Tasigna to reflect that certain patients with a type of leukemia may be eligible to stop treatment after sustained response

Pharma Reviews: Only pharmacists can stop fake drug menace: Punjab Governor

Inaugurating the three-day 69th Indian Pharmaceutical Congress (IPC) at the Chitkara University Campus here on Friday, Punjab Governor V P Singh Badnore said that pharmacists had a key role to play in stopping the menace of fake drugs entering the market. He called upon pharmaceutical ...
Read more: Only pharmacists can stop fake drug menace: Punjab Governor

Pharma Reviews: A Glorious Kick Start to 69th Indian Pharma Congress at Chitkara University

69th Indian Pharmaceutical Congress (IPC), a three day International Conference between December 22-24, 2017, kick started at Chitkara University, Punjab campus with a grand and glorious inaugural ceremony presided by Sh. V. P. Badnore (Hon'ble Governor of Punjab), Sh. Brahm Mohinder Singh ...
Read more: A Glorious Kick Start to 69th Indian Pharma Congress at Chitkara University

Pharma Reviews: India pharma exports to touch $20 billion by 2020: Study

Indian pharmaceutical exports are likely to touch $20 billion by 2020 from the current level of around $16.5 billion, registering a compounded annual growth rate (CAGR) of about 30 percent, reveals ASSOCHAM and UL India joint study. Indian pharmaceutical sector is expected to register a growth of ...
Read more: India pharma exports to touch $20 billion by 2020: Study

US FDA News: FDA clears stereotactic radiotherapy system for use in treating breast cancer

FDA clears stereotactic radiotherapy system for use in treating breast cancer
Read more: FDA clears stereotactic radiotherapy system for use in treating breast cancer

Pharma Reviews: Indian Pharma Market All Set for a Boom

The Indian pharmaceutical industry is the largest producer of Generics and the market in this segment is expected to see a further boom, along with speciality medicines like Bio-similars owing to many patented products going off patent, says Rahul Darda, Chairman and Managing Director, Brinton ...
Read more: Indian Pharma Market All Set for a Boom

Pharma Reviews: 69th IPCE to flag concerns over import of raw material for drugs

We will be having technical sessions by industry bigwigs during the three-day Congress. In fact, Prof. B Suresh, President, Pharmacy Council of India(PCI) and Dr. G N Singh, Drug Controller General of India, will be attending the inaugural session from 11 a.m. onwards on Dec 22. The theme of the ...
Read more: 69th IPCE to flag concerns over import of raw material for drugs

Pharma Reviews: India pharma exports to touch USD 20 bn by 2020: Study

Indian pharmaceutical exports are likely to touch USD 20 billion by 2020 from the current level of around USD 16.5 billion, registering a compounded ... India is the third-largest global generic Active Pharmaceutical Ingredient (API) manufacturer in terms of market share and generic drugs form the largest ...
Read more: India pharma exports to touch USD 20 bn by 2020: Study

Pharma Reviews: GlobalSpace Technologies launches DocExa to create digital health eco-system

Speaking to Pharmabiz at the launch of the DocExa, Krishna Singh, founder, chairman & managing director, GlobalSpace Technologies said, “DocExa is the industry's first AI driven doctor-pharmaceutical-patient connect platform. Its a step forward towards digital India and by digitally connecting the ...
Read more: GlobalSpace Technologies launches DocExa to create digital health eco-system

Pharma Reviews: India's unpredictable policies affect investments into pharma sector: OPPI

India's unpredictable business environment and lack of infrastructure are the barriers that pharma industry is facing today. The government must lead the way in bringing together world-class infrastructure (research centers) in India to bring newer medicines, treatments and address the unmet medical ...
Read more: India's unpredictable policies affect investments into pharma sector: OPPI

Pharma Reviews: 69th IPCE to flag concerns over import of raw material for drugs

Chandigarh [India], Dec.21 : The 69th Indian Pharmaceutical Congress and Exhibition (IPCE) to be held from December 22-24 here, is expected to focus on flag its concern over India's dependence on import of Active Pharmaceutical Ingredients(API), the crucial raw material for manufacturing drugs.
Read more: 69th IPCE to flag concerns over import of raw material for drugs

US FDA News: FDA approves drug to treat dangerously low blood pressure

The FDA today approved the new drug Giapreza (angiotensin II) injection for intravenous infusion to increase blood pressure in adults with septic or other distributive shock.
Read more: FDA approves drug to treat dangerously low blood pressure

Pharma Reviews: Eased NPPA drug approvals to inject growth into sector

“It is a positive move and will help in ease of doing business,” said Deepnath Roy Chowdhury, president of Indian Drug Manufacturers' Association (IDMA). Cipla declined to comment, while other firms did not respond to queries on the issue. “The NPPA was sitting on applications and was not clearing ...
Read more: Eased NPPA drug approvals to inject growth into sector

Pharma Reviews: Third generation joins DRL

Hyderabad: After being steered by the doyen of the pharma industry, Kallam Anji Reddy, and then jointly driven by his son, Satish Reddy, and son-in-law ... from Hyderabad Public School, Ravi did his BTech from IIT-Bombay in chemical engineering and MBA from premier city-based B-School, the Indian ...
Read more: Third generation joins DRL

Pharma Reviews: Dr Reddy's board gives nod to induct third generation leadership into the company

In pharma sector, finding next level of growth could be challenging task for leadership, believes Tambe. Indian pharmaceutical industry grew at impressive rates in the last two decades on back of generic drugs. However, in last two to three years, companies are increasingly facing pressure on pricing ...
Read more: Dr Reddy's board gives nod to induct third generation leadership into the company

Pharma Reviews: Despite 40% dip in interest in pharma sector jobs, Indian youths throng for Ayurveda jobs in 2017

The number of employees in India seeking to work with the Ayurveda industry has surged significantly when compared to last year, found a leading job search engine Indeed. The spike in interest is attributed to the efforts taken by the government and the home-grown Ayurvedic companies in spreading ...
Read more: Despite 40% dip in interest in pharma sector jobs, Indian youths throng for Ayurveda jobs in 2017

Pharma Reviews: Wockhardt's Habil Khorakiwala Unveils - Odyssey of Courage

The program will entail 12 sessions with Mr. Khorakiwala to help build careers and take businesses to the next level. Commenting on the occasion, Habil Khorakiwala said, "The book chronicles the journey of the Indian Pharma industry, Wockhardt and me. It highlights how important it is to dream big ...
Read more: Wockhardt's Habil Khorakiwala Unveils - Odyssey of Courage

Pharma Reviews: IPCE-17 to focus on Skill development and affordable medicines

Chandigarh, Dec 21 (UNI) Indian Pharmaceutical Congress & Exhibition (IPCE), a National convention of pharmacists, pharma academia, industry and senior Central and State Governments Regulatory officers, will commence at the Chitkara University Campus in Chandigarh, from December 22.
Read more: IPCE-17 to focus on Skill development and affordable medicines

Pharma Reviews: India pharma exports to touch $20 bln by 2020: study

Indian pharmaceutical exports are likely to touch $20 billion by 2020 from the current level of around $16.5 billion, registering a compounded annual growth rate (CAGR) of about 30 per cent, reveals ASSOCHAM and UL India joint study. Indian pharmaceutical sector is expected to register a growth of ...
Read more: India pharma exports to touch $20 bln by 2020: study

Pharma Reviews: 69th IPCE to flag concerns over import of raw material for drugs

The 69th Indian Pharmaceutical Congress and Exhibition (IPCE) to be held from December 22-24 here, is expected to focus on flag its concern over India's dependence on import of Active Pharmaceutical Ingredients(API), the crucial raw material for manufacturing drugs. According to Dr.Shailendra ...
Read more: 69th IPCE to flag concerns over import of raw material for drugs

Pharma Reviews: India developing bulk drugs to reduce import dependence: DCGI

New Delhi, Dec 20 : India is in the process of developing a range of bulk drugs to reduce import dependence, especially from China, a top government official said today. Although a large quantity of bulk drugs is imported from China, India has enough capacity for producing active pharmaceutical ...
Read more: India developing bulk drugs to reduce import dependence: DCGI

US FDA News: Long-Acting Beta agonists (LABAs) and Inhaled Corticosteroids (ICS): Drug Safety Communication - Boxed Warning About Asthma-Related Death Removed

FDA review of clinical safety trials shows that treating asthma with LABAs in combination with ICS does not result in significantly more serious asthma-related side effects than treatment with ICS alone.
Read more: Long-Acting Beta agonists (LABAs) and Inhaled Corticosteroids (ICS): Drug Safety Communication - Boxed Warning About Asthma-Related Death Removed

Pharma Reviews: National Pharmaceutical Pricing Authority eases norms for new drug approvals

The pharma industry welcomed the step. “These are definitely positive steps taken by the NPPA. These rules were causing a lot of complications, this is therefore a relief to some extent,” said Deepnath Roy Chowdhury, national president, Indian Drugs Manufacturers' Association (IDMA). The launch of ...
Read more: National Pharmaceutical Pricing Authority eases norms for new drug approvals

Pharma Reviews: India may levy anti-dumping duty on Ofloxacin Acid imported from China

NEW DELHI: India is likely to impose antidumping duty of up to USD 8.55 per kg on Chinese imports of a chemical, used mainly by the pharma industry, to protect local manufacturers from below-cost shipments. The Directorate-General of Antidumping and Allied Duties (DGAD) said it has established ...
Read more: India may levy anti-dumping duty on Ofloxacin Acid imported from China

US FDA News: Pantoprazole Sodium for Injection 40 Mg Per Vial: Recall - Presence of Glass Particles

Administration of a glass particulate may result in local irritation or swelling in response to the foreign material. More serious potential outcomes would include blockage and clotting in blood vessels, which may be life-threatening.
Read more: Pantoprazole Sodium for Injection 40 Mg Per Vial: Recall - Presence of Glass Particles

Pharma Reviews: 'Let your work speak for yourself', says Indian management association's Rekha Sethi

The Director General of All India Management Association (AIMA) Rekha Sethi finds a place on the Board of Directors of some leading companies like Sun Pharmaceutical Industries. An student of English from St Stephen's College in Delhi, Rekha started her career with Centre for Development of ...
Read more: 'Let your work speak for yourself', says Indian management association's Rekha Sethi

Pharma Reviews: India may levy antidumping duty on O-acid imported from China

New Delhi, Dec 20 (PTI) India is likely to impose antidumping duty of up to USD 8.55 per kg on Chinese imports of a chemical, used mainly by the pharma industry, to protect local manufacturers from below-cost shipments. The Directorate-General of Antidumping and Allied Duties (DGAD) said it has ...
Read more: India may levy antidumping duty on O-acid imported from China

Pharma Reviews: Wockhardt's Habil Khorakiwala unveils his autobiography 'Odyssey of Courage'

Wockhardt's Habil Khorakiwala has unveiled his autobiography – Odyssey of Courage. The book recounts four different transformation journeys from the time he started his company and survived in the first 10 to 15 years to become an important national pharmaceutical organisation, after liberalisation ...
Read more: Wockhardt's Habil Khorakiwala unveils his autobiography 'Odyssey of Courage'

Pharma Reviews: Wockhardt's Habil Khorakiwala unveils Odyssey of Courage

The programme will entail 12 sessions with Mr Khorakiwala to help build careers and take businesses to the next level. Commenting on the occasion, Mr Khorakiwala said the book chronicles the journey of the Indian Pharma industry, Wockhardt and him. It highlights how important it is to dream big and ...
Read more: Wockhardt's Habil Khorakiwala unveils Odyssey of Courage

Pharma Reviews: Sanofi India elevates N. Rajaram as Managing Director

In a recent announcement, pharma company Sanofi India, has elevated N. Rajaram as managing director. The new role will be effective from January 1, 2018. Rajaram joined the company in January 2014 and was appointed as whole time director in October 2015. Rajaram has nearly two decades of ...
Read more: Sanofi India elevates N. Rajaram as Managing Director

Pharma Reviews: Outlook 2018 : Investments in R & D essential to keep up with market needs

One important market in this regard is India, a very important country for the international health care industry. Indian pharma companies already have the highest number of USFDA approved products but have been mainly focused on generics. In the next year and years, it will become one of the more ...
Read more: Outlook 2018 : Investments in R & D essential to keep up with market needs

US FDA News: Defibrillation Electrodes for Lifepak AEDs by Physio-Control: Class I Recall - Incorrect Placement Instructions for Infants Depicted on Artwork

Incorrect placement of electrodes on an infant may result in failure to deliver an effective shock. A delay in therapy could result in serious injury and/or death.
Read more: Defibrillation Electrodes for Lifepak AEDs by Physio-Control: Class I Recall - Incorrect Placement Instructions for Infants Depicted on Artwork

US FDA News: FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss

FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss
Read more: FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss

US FDA News: Gadolinium-based Contrast Agents (GBCAs): Drug Safety Communication - Retained in Body; New Class Warnings

Trace amounts of gadolinium may stay in the body long-term.
Read more: Gadolinium-based Contrast Agents (GBCAs): Drug Safety Communication - Retained in Body; New Class Warnings

Pharma Reviews: Over dependence on drug imports from China harmful for India: IPCA

According to the IPCA, over 75 percent of India's bulk drug imports come from China. That, according to the IPCA, means that India sources around 80 per cent of pharma raw materials to meet growing requirements of drug formulations for Indian pharmaceutical industry. This has emerged as a cause of ...
Read more: Over dependence on drug imports from China harmful for India: IPCA

Pharma Reviews: Lincoln Pharma gets patent for anti-malarial drug

The patent has been awarded by the Indian government for an Arteether injection to treat malaria, according to a BSE filing. The drug is painless and gives faster relief to the patients, Lincoln Pharma said. The company expects significant rise in the revenue from exports to Africa after the introduction of ...
Read more: Lincoln Pharma gets patent for anti-malarial drug

Pharma Reviews: Over dependence on drug imports from China harmful for India: IPCA

New Delhi [India], Dec.19 : An overwhelming dependence on drug imports and related raw materials from China could prove harmful for the health sector in India in the long run, the Indian Pharmaceutical Congress Association (IPCA) has said. According to the IPCA, over 75 percent of India's bulk drug ...
Read more: Over dependence on drug imports from China harmful for India: IPCA

Pharma Reviews: Having run around for parents' medicine, this entrepreneur now makes healthcare a seamless ...

Electronic prescriptions made paper redundant, and Tushar says he was also told which pharmacy would have stock of the medicines he required. ... The Indian pharma industry is currently pegged at $15 billion, and some of the issues that the sector faces include low fill-rates, delivery delays, and ...
Read more: Having run around for parents' medicine, this entrepreneur now makes healthcare a seamless ...

Pharma Reviews: Twin boost for Modi's reforms: What it means for pharma?

After GST rollout, pharma units in Gujarat will have a level-playing field to compete with the states offering tax incentives. We expect more than 50 units to return to Gujarat, and that will improve our share in the India's pharma sector,” said Nirav Mehta, Vice-Chairman, Gujarat State Board of Indian Drug ...
Read more: Twin boost for Modi's reforms: What it means for pharma?

US FDA News: FDA proposes new, risk-based enforcement priorities to protect consumers from potentially harmful, unproven homeopathic drugs

Today, the U.S. Food and Drug Administration proposed a new, risk-based enforcement approach to drug products labeled as homeopathic. To protect consumers who choose to use homeopathic products, this proposed new approach would update the FDA’s existing policy to better address situations where homeopathic treatments are being marketed for serious diseases and/or conditions but where the products have not been shown to offer clinical benefits. It also covers situations where products labeled as homeopathic contain potentially harmful ingredients or do not meet current good manufacturing practices.
Read more: FDA proposes new, risk-based enforcement priorities to protect consumers from potentially harmful, unproven homeopathic drugs

Pharma Reviews: Top stocks in focus on 18 December 2017

Adani Enterprises: India's Adani said on Monday it had canceled plans with Downer EDI Ltd to help develop and run its Carmichael coal mine in Australia after ... DRL, Aurobindo Pharma: Indian drug companies Aurobindo Pharma and Dr Reddy's Laboratories are emerging as the frontrunners to buy out ...
Read more: Top stocks in focus on 18 December 2017

Pharma Reviews: Drug makers can now expect more regular checkups from USFDA

A comparative analysis of FDA inspections in EU, China and India shows higher inspection coverage leads to lower rates of manufacturing violations. During 2010-15, the number of FDA inspections of Indian companies more than doubled to 270 from 108, indicating tighter regulatory oversight. Almost a ...
Read more: Drug makers can now expect more regular checkups from USFDA

Pharma Reviews: Aurobindo, Dr Reddy's Laboratories frontrunners to buy out bankrupt Orchid Pharma

Lakshmi Vilas Bank referred Chennai-based Orchid Pharma to the National Company Law Tribunal for defaulting on repayments to the tune of Rs 50 crore. The company owes more than Rs 3,500 crore to a group of lenders led by the State Bank of India. It was on the Reserve Bank of India's second list ...
Read more: Aurobindo, Dr Reddy's Laboratories frontrunners to buy out bankrupt Orchid Pharma

Pharma Reviews: 'Online pharmacy huge health risk'

New Delhi [India], Dec 17 (ANI): Indian pharmacists fear rise in self-medication and abuse unless online drug sales are checked. In the run up to the 69th Indian Pharmaceutical Congress to be held from December 22-24 in Chandigarh, the hosts of the event Indian Pharmaceutical Congress Association ...
Read more: 'Online pharmacy huge health risk'

Pharma Reviews: Beware price controls on medicines: It will deter pharma industry and choke the supply of quality ...

That in turn will affect the ability and willingness of Indian pharma companies to invest in capacity expansion and research spending which at present is in the range of 8-10% of their sales revenue compared to 20% for multinationals. Obviously, if indigenous pharma companies aren't able to fund the ...
Read more: Beware price controls on medicines: It will deter pharma industry and choke the supply of quality ...

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on new FDA efforts to support more efficient development of targeted therapies

FDA issues two draft guidances that will provide medical product developers with greater clarity on the FDA’s recommendations for researching and developing the next generation of individualized therapies.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on new FDA efforts to support more efficient development of targeted therapies

Pharma Reviews: Volkswagen ups prices up to Rs 20000 from Jan

Amway Queen cookware crosses Rs 100-cr sales Direct selling firm Amway India has said its Amway Queen, the premium cookware range has crossed ... formulations biz to Torrent Pharma firm Unichem Laboratories has completed the sale and transfer of its domestic formulations business in India and ...
Read more: Volkswagen ups prices up to Rs 20000 from Jan

Pharma Reviews: Supreme Court refers fixed dose combination drugs issue to govt expert body

The ban covered about 6,000 brands from major pharma houses including Pfizer Ltd, Wockhardt Ltd, Alkem Laboratories Ltd, Cipla Ltd, Sanofi India Ltd, and Sun Pharmaceutical Industries Ltd. It was enforced following a report by a six-member committee headed by Chandrakant Kokate, vice-chancellor ...
Read more: Supreme Court refers fixed dose combination drugs issue to govt expert body

Pharma Reviews: Volkswagen ups prices up to Rs 20000 from Jan

Unichem sells domestic formulations biz to Torrent Pharma firm Unichem Laboratories has completed the sale and transfer of its domestic formulations business in India and Nepal, by way of a slump sale to Torrent Pharma. Last month, Torrent announced that it would acquire branded business of ...
Read more: Volkswagen ups prices up to Rs 20000 from Jan

US FDA News: Blue Pearl All Natural Male Enhancement Supplement: Recall - Undeclared Drug Ingredient

Undeclared sildenafil may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may lower blood pressure to dangerous levels.
Read more: Blue Pearl All Natural Male Enhancement Supplement: Recall - Undeclared Drug Ingredient

Pharma Reviews: Torrent Pharma completes acquisition of Unichem Laboratories Ltd

The acquisition will accelerate Torrent's presence in the chronic space especially in the high growth segments of Indian Pharma market like Cardiology, Diabetology and Gastroenterology. Moreover, Unichem brings in an important new platform in Torrent's sustainable growth strategy by expanding the ...
Read more: Torrent Pharma completes acquisition of Unichem Laboratories Ltd

Pharma Reviews: How US Tax Reforms May Impact India Inc.

So which Indian sectors are likely to get impacted the most? IT-ITES, pharmaceuticals and contract manufacturing are the sectors that would definitely be affected said Maulik Doshi, partner at SKP Business Consulting. Rupak Saha, tax partner at PWC India was more circumspect about the impact of the ...
Read more: How US Tax Reforms May Impact India Inc.

Pharma Reviews: CPhI-P-MEC India Expo 2017 Catapults the Pharma Sector to New Heights

UBM India, India's leading B2B exhibition organizer, enthralled the pharma industry and brought it to a standstill with the grand 11th edition of its signature event, CPhI & P-MEC India 2017, that was held at two venues in Mumbai - MMRDA Grounds, Bandra-Kurla Complex (27^th to 29^th November) and ...
Read more: CPhI-P-MEC India Expo 2017 Catapults the Pharma Sector to New Heights

Pharma Reviews: Kochi fast emerging as petrochemical hub

KOCHI: Kochi is set to become a major hub for the petrochemical industry in India with the BPCL Kochi Refinery, Kerala State Industrial Development Corporation (KSIDC) and Kerala Industrial Infrastructure ... An area of 30-40 acres in the park will be earmarked for pharma companies'' he added.
Read more: Kochi fast emerging as petrochemical hub

US FDA News: FDA launches new tool for sharing information that allows doctors to better manage antibiotic use; improve patient care

Today the FDA is announcing a new approach to get critical updates regarding antibiotics and antifungal drugs to health care professionals as part of an overall effort to combat antimicrobial resistance. The agency created a website that will provide direct and timely access to information about when bacterial or fungal infections are likely to respond to a specific drug.
Read more: FDA launches new tool for sharing information that allows doctors to better manage antibiotic use; improve patient care

Pharma Reviews: The US Squeeze

The way India's largest drug maker Sun Pharmaceutical rose and fell in the US, a country that accounts for 44 per cent of the $1.1 trillion global drug market, is an indication of the challenges that the Indian pharmaceutical industry is facing in that market. Sun entered the US in 2008/09 by acquiring ...
Read more: The US Squeeze

Pharma Reviews: Growing Worries

The India pharmaceutical industry is incredible in more ways than one. On the one hand, it takes pride in the fact that India is home to the largest number of drug-making facilities outside the US that are approved by the US Food and Drug Administration (USFDA) - over 600 of them. And in the fact that ...
Read more: Growing Worries

Pharma Reviews: Women Achievers- KANCHANA TK

Being one among the very few women who make it to senior roles in industry, Kanchana TK, Director General, Organisation of Pharmaceutical Producers of India (OPPI) has not hesitated to make bold career moves. Her professional experience of over two decades at the leading edge of a spectrum of ...
Read more: Women Achievers- KANCHANA TK

Pharma Reviews: No Easy Cure

The pharmaceutical industry in India is in serious need of a strategy rethink. Constant policy interventions for over a year and the growing uncertainties around those have sorely hit the sector, so much so that the key players are determined to get better of those deterrents and regain their growth ...
Read more: No Easy Cure

Pharma Reviews: Drug Wars

It was a tough call as import of these low-cost key active pharmaceutical ingredients (APIs), or raw materials - almost entirely from China - was helping Indian formulation companies, or entities that make syrups, tablets, injections, etc, remain competitive. An increase in medicine prices due to rise in input ...
Read more: Drug Wars

US FDA News: FDA approves first drug for Eosinophilic Granulomatosis with Polyangiitis, a rare disease formerly known as the Churg-Strauss Syndrome

FDA approves first drug for a rare autoimmune disease that causes an inflammation in the wall of blood vessels of the body. This is a new indication for a previously-approved drug.
Read more: FDA approves first drug for Eosinophilic Granulomatosis with Polyangiitis, a rare disease formerly known as the Churg-Strauss Syndrome

US FDA News: FDA warns companies for promoting alternatives to street drugs

The FDA today posted a warning letter to the marketers and distributors of Legal Lean Syrup, a drink, and Coco Loko, a “snortable” chocolate powder, for selling unapproved new drugs and misbranded drugs.
Read more: FDA warns companies for promoting alternatives to street drugs

Pharma Reviews: Antibiotics & asthma drugs help Indian pharma market to grow at 8.1% in Nov

The Indian pharmaceutical market (IPM) grew 8.1 percent in November, the highest growth for any month so far in FY18, helped by improved uptake in anti-infectives, respiratory and gastrointestinal segments, despite gradual recovery from the disruption caused by GST transition, according to market ...
Read more: Antibiotics & asthma drugs help Indian pharma market to grow at 8.1% in Nov

Pharma Reviews: 'India Inc's November M&A deal tally grows 55% to $3 bn'

NEW DELHI: India Inc's merger and acquisition activity registered a growth of 55 per cent year- on-year in November with deals worth USD 3.2 billion, ... November also witnessed Torrent Pharma's biggest acquisition till date with Unichem Laboratories' Indian and Nepal businesses for USD 554 million.
Read more: 'India Inc's November M&A deal tally grows 55% to $3 bn'

Product Recall Alerts: Inmar Acquires RASMAS from Noblis

Inmar, a leading provider of recall and product withdrawal services for both pharmaceutical and consumer goods in the U.S. and Canada, has served as the exclusive reseller of RASMAS on behalf of Noblis, Inc. for the past eight years. RASMAS helps its pharmacy clients reduce alert processing time by ...
Read more: Inmar Acquires RASMAS from Noblis

US FDA News: FDA approves Admelog, the first short-acting "follow-on" insulin product to treat diabetes

The FDA today approved Admelog (insulin lispro injection), a short-acting insulin indicated to improve control in blood sugar levels in adults and pediatric patients 3 years and older with type 1 diabetes mellitus and adults with type 2 diabetes mellitus. Admelog is the first short-acting insulin approved as a “follow-on” product.
Read more: FDA approves Admelog, the first short-acting "follow-on" insulin product to treat diabetes

US FDA News: FDA launches public education campaign to encourage adult smokers trying to quit cigarettes

Today, the U.S. Food and Drug Administration announced an adult smoking cessation education campaign aimed at encouraging cigarette smokers to quit through messages of support that underscore the health benefits of quitting. These messages will be displayed in and around gas stations and convenience stores – retail locations where smokers face a multitude of triggers and that typically feature cigarette advertisements. The “Every Try Counts” campaign targets smokers ages 25-54 who have attempted to quit smoking in the last year but were unsuccessful. The two-year campaign launches next month in 35 U.S. markets and features print, digital, radio, and out-of-home ads, such as on billboards.
Read more: FDA launches public education campaign to encourage adult smokers trying to quit cigarettes

Pharma Reviews: Schott Kaisha introduces path breaking innovation in pharma packaging

Schott Kaisha has introduced state-of-the art technologies and path-breaking innovations in the pharmaceutical primary packaging space. With its advanced operational capabilities, Schott Kaisha was the first manufacturer of glass syringes and cartridges in India, and continues to be a prime supplier for ...
Read more: Schott Kaisha introduces path breaking innovation in pharma packaging

Pharma Reviews: Indian pharma market improves by 8.1% to Rs.10291 crore in Nov'17

Indian Pharmaceutical Market (IPM) improved during the month of November 2017 due to positive growth in volumes. According to AIOCD Pharmasofttech AWACS Pvt. Ltd, IPM has clocked growth of 8.1 per cent to Rs.10,291 crore. However, due to GST implementation, the growth in April-November for ...
Read more: Indian pharma market improves by 8.1% to Rs.10291 crore in Nov'17

Pharma Reviews: Closing bell: Sensex gains 205 pts, Nifty closes above 10300; paper stocks rally

2:50 pm Market Outlook: BNP Paribas maintains its overweight stance on Indian markets and sees the S&P BSE Sensex heading towards 37,500, .... 12:40 pm USFDA Inspection: Pharma firm Granules India today said its US subsidiary has received an observation from the USFDA on completion of ...
Read more: Closing bell: Sensex gains 205 pts, Nifty closes above 10300; paper stocks rally

Pharma Reviews: Investors Prefer Mid Caps Over Large Caps In Indian Pharma Sector, Macquarie Says

Brokerage house Macquarie said Asian investors prefer mid-cap pharma companies over their larger counterparts where they remain cautious. Most investors are wary of investing in the U.S. centric large-cap stocks after the massive stock price correction over the last one-and-a-half to two years, the ...
Read more: Investors Prefer Mid Caps Over Large Caps In Indian Pharma Sector, Macquarie Says

Pharma Reviews: Pharma sector bats for higher standards

The captains of the Indian pharmaceutical industry have stressed on the need to achieve high quality standards to enable India partake a large part of the global pharmaceutical market. The emphasis comes in the wake of multiple negative actions taken by the USFDA against products and facilities of ...
Read more: Pharma sector bats for higher standards

Pharma Reviews: TCS biggest wealth creator in 2012-17, Ajanta Pharma the fastest: Wealth Creation Study

Anuj: It is interesting we have been talking about a bear market for pharmaceutical but for last three years it is a pharmaceutical company which have been the fastest wealth creator, Ajanta Pharma. In the past also we have seen couple of pharmaceutical companies do that. So do you think Indian ...
Read more: TCS biggest wealth creator in 2012-17, Ajanta Pharma the fastest: Wealth Creation Study

Pharma Reviews: Is Indian Bioeconomy outgrown the Pharma industry?

ABLE, a biotech industry lobby group formed in 2003, in its report noted that the Indian bioeconomy has crossed $42 billion in 2017 and biotechnology industry is valued at $19 billion. Contrary to this, India Brand Equity Foundation (IBEF), in its Biotechnology Sector Report - March 2017 referring to ...
Read more: Is Indian Bioeconomy outgrown the Pharma industry?

US FDA News: Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for oral testimony before the U.S. Senate Committee on Health, Education, Labor & Pensions Hearing, “Implementation of the 21st Century Cures Act: Progress and the Path Forward for Medical Innovation

FDA Commissioner Gottlieb testifies before the U.S. Senate Committee on Health, Education, Labor & Pensions on the agency’s implementation of the 21st Century Cures Act
Read more: Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for oral testimony before the U.S. Senate Committee on Health, Education, Labor & Pensions Hearing, “Implementation of the 21st Century Cures Act: Progress and the Path Forward for Medical Innovation

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on advancing new digital health policies to encourage innovation, bring efficiency and modernization to regulation

Statement from FDA Commissioner Scott Gottlieb, M.D., on advancing new digital health policies to encourage innovation, bring efficiency and modernization to regulation
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on advancing new digital health policies to encourage innovation, bring efficiency and modernization to regulation

Pharma Reviews: Agri Buzz: SEA of India Estimates 93 percent Rise In Oilmeal Exports During November 2017

As per the latest release by Solvent Extractors Association of India (SEA OF India), the export during November 2017 is provisionally reported at 328,091 tons ... This steps will make Indian oilmeal more competitive in the world market and may result in to larger export of oilmeals during current year.
Read more: Agri Buzz: SEA of India Estimates 93 percent Rise In Oilmeal Exports During November 2017

Pharma Reviews: Precision medicine: Zuckerberg backs Indian-origin scientist with formula to jolt drug market

What Butte aims to do in simple terms is drug re-positioning - can an old medicine treat a new or another disease? It is not about getting a new drug out in the market, but finding a new use for an old drug that we already have. This is significant because big pharma spends billions of dollars and decades ...
Read more: Precision medicine: Zuckerberg backs Indian-origin scientist with formula to jolt drug market

Pharma Reviews: Economic Buzz: Australia Construction Activity Climbs To 4-Month High In November

By clicking on submit button, you authorize IIFL & its representatives & agents to provide information about various products, offers and services provided by IIFL through any mode including telephone calls, SMS, letters etc. . you confirm that laws in relation to unsolicited communication referred in ...
Read more: Economic Buzz: Australia Construction Activity Climbs To 4-Month High In November

Pharma Reviews: IVCA, Quadria Capital to host India Healthcare Leadership Summit 2017 on December 7 at Taj ...

IVCA, Quadria Capital to host India Healthcare Leadership Summit 2017 on December 7 at Taj Lands End Hotel, Mumbai ... Industry experts, professionals and leaders from country's leading private equity fund houses, healthcare companies, hospitals, pharma companies, consulting ventures and tax ...
Read more: IVCA, Quadria Capital to host India Healthcare Leadership Summit 2017 on December 7 at Taj ...

Pharma Reviews: IVCA & Quadria Capital to Host India Healthcare Leadership Summit 2017

At IVCA, we are setting up a platform for the overall healthcare industry to get together and discuss aspects from around regulatory landscape, generics, biosimilars, investor perspective on healthcare delivery and healthcare startups. With this, we aim output driven discussions on relevant and burning ...
Read more: IVCA & Quadria Capital to Host India Healthcare Leadership Summit 2017

Pharma Reviews: This Indian company is ready to flood the US with cheap HIV drugs

In the U.S., Laurus will be going up against much larger companies like Teva Pharmaceutical Industries Ltd. — the world's biggest generic drug company — which will beat it to market on generic Viread and so be the first to slash prices and lock down customers. Other generic companies, both from India ...
Read more: This Indian company is ready to flood the US with cheap HIV drugs

Pharma Reviews: This company is ready to flood the US with cheap HIV drugs

For generic manufacturers like Laurus, the U.S. market is alluring. ... he left his job as a C-suite executive at another Indian pharma company to found ...
Read more: This company is ready to flood the US with cheap HIV drugs

Pharma Reviews: Indiabulls Pharma raises ₹155 cr from Clermont Group

Indiabulls Pharmaceuticals, an Indiabulls Group company, has raised ₹155 crore from Singapore-based investment firm Clermont Group. The company will use the investments to strengthen its healthcare products and services in India, with the intention of being amongst the top 10 players in the coming ...
Read more: Indiabulls Pharma raises ₹155 cr from Clermont Group

US FDA News: Pharmacist Choice Alcohol Prep Pads by Simple Diagnostics: Recall - Lack of Sterility Assurance and Other Quality Issues

The use of impacted alcohol prep pads could result in adverse events such as infections.
Read more: Pharmacist Choice Alcohol Prep Pads by Simple Diagnostics: Recall - Lack of Sterility Assurance and Other Quality Issues

Pharma Reviews: NZ billionaire backs Indiabulls Pharma

The company "is aiming to reshape the Indian pharmaceutical industry landscape by providing next-generation therapies to patients at affordable ...
Read more: NZ billionaire backs Indiabulls Pharma

Pharma Reviews: Indiabulls Pharma receives Rs 155 crore investment from Clermont Group

“At Indiabulls Pharmaceuticals, we want to reshape the Indian pharmaceutical industry landscape by providing next generation therapies to patients at affordable prices. We aspire to be a patient and physician centric, innovative, best-in-class pharmaceutical company,” said Mr. Nikhil Chari, CEO of ...
Read more: Indiabulls Pharma receives Rs 155 crore investment from Clermont Group

Pharma Reviews: Laurus Labs is ready to flood the US with cheap HIV drugs

In the US, Laurus will be going up against much larger companies like Teva Pharmaceutical Industries Ltd — the world's biggest generic drug company — which will beat it to market on generic Viread and so be the first to slash prices and lock down customers. Other generic companies, both from India ...
Read more: Laurus Labs is ready to flood the US with cheap HIV drugs

Pharma Reviews: Abuse of drugs

Almost 50 per cent of India's Rs 2.20-lakh-crore annual revenue of the pharmaceutical industry comes from exports. They are under constant regulatory control in the US and Europe on quality, production procedure, packaging and price. The producers can't grumble. Either they fall in line or they lose ...
Read more: Abuse of drugs

US FDA News: Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA ushering in new era of 3D printing of medical products; provides guidance to manufacturers of medical devices

The FDA is issuing final guidance on the technical considerations for the 3D printing of medical devices. The recommendations clarify what the FDA recommends manufacturers include in submissions for 3D printed medical products.
Read more: Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA ushering in new era of 3D printing of medical products; provides guidance to manufacturers of medical devices

Pharma Reviews: This Company Is Ready to Flood the US With Cheap HIV Drugs

In the U.S., Laurus will be going up against much larger companies like Teva Pharmaceutical Industries Ltd. -- the world's biggest generic drug company -- which will beat it to market on generic Viread and so be the first to slash prices and lock down customers. Other generic companies, both from India ...
Read more: This Company Is Ready to Flood the US With Cheap HIV Drugs

Pharma Reviews: AVPS Chakravarthi honoured at India Pharma awards

Chakravarthi said, “The very recognition of a packaging technologist at India Pharma Awards reiterates the growing importance of packaging in the pharmaceutical sector. Pharma packaging is close to my heart and though it lacks glamour it has all other ingredients and host of challenges as well.”.
Read more: AVPS Chakravarthi honoured at India Pharma awards

Pharma Reviews: Growth policies being drawn up for each sector: Prabhu

Commerce Minister Suresh Prabhu Friday said that the government is working towards drawing up policies for various sectors of the Indian economy ... on the pharma sector, Prabhu said the latter had spoken of $100 billion worth of business being achievable by the Indian pharma and biotech industry.
Read more: Growth policies being drawn up for each sector: Prabhu

Pharma Reviews: Urging support, Pharma Sector to present white paper before the government

New Delhi, Dec 2 (KNN) Pharma industry leaders and stakeholders participated in a discussion on Indian Pharmaceutical Industry in a CEO Round Table as part of the 2nd edition of India Pharma Week, a UBM India initiative introduced to celebrate a decade of CPhI & P-MEC. The industry would soon ...
Read more: Urging support, Pharma Sector to present white paper before the government

Pharma Reviews: India's top 20% pharmaceutical workforce is on par with global standards: Uma Nandan Misra

The move to be aggressive in training candidates also ensues from the Drugs Control General of India's notification which has targeted that by 2018, pharma sector personnel will need focused training across specializations. In order to play a critical role generating the trained workforce, Pharma ...
Read more: India's top 20% pharmaceutical workforce is on par with global standards: Uma Nandan Misra

Pharma Reviews: Nifty, Sensex May Remain Weak – Weekly closing report

The key Indian equity indices on Monday were trading lower on Monday, in line with the closing values of Asian indices. ... Shares of Sun Pharmaceutical Industries slipped nearly 2% in early trade on Monday after the pharma company on Friday announced that its US-based subsidiary is recalling two ...
Read more: Nifty, Sensex May Remain Weak – Weekly closing report

US FDA News: FDA approves first biosimilar for the treatment of certain breast and stomach cancers

FDA approves first biosimilar for the treatment of certain breast and stomach cancers
Read more: FDA approves first biosimilar for the treatment of certain breast and stomach cancers

Pharma Reviews: DRL's subsidiary receives FDA nod for anti-psoriasis cream

A statement from the drug maker said it is a first-cycle NDA (new drug application) approval for the Proprietary Products Group, a substantial milestone within the pharmaceutical industry. Impoyz (clobetasol propionate) cream, 0.025 per cent, is a high-potency topical steroid approved for the treatment of ...
Read more: DRL's subsidiary receives FDA nod for anti-psoriasis cream

US FDA News: Albumin Human 25 Percent Solution (AlbuRx 25): Product Information Advisory - Fading Print On Label

Potential for fading print, with more effect on the expiration dating on the patient tear off portion of the vial label.
Read more: Albumin Human 25 Percent Solution (AlbuRx 25): Product Information Advisory - Fading Print On Label

US FDA News: Bull Capsules, Chao Jimengnan Tablets by Nutra Labs: Recall - Undeclared Drug Ingredients

Undeclared sildenafil may interact with nitrates found in some prescription drugs (such as nitroglycerin) and may cause a significant drop in blood pressure that may be life threatening.
Read more: Bull Capsules, Chao Jimengnan Tablets by Nutra Labs: Recall - Undeclared Drug Ingredients

Pharma Reviews: Growth policies being drawn up for each sector: Prabhu

Informing the audience that he had met with IT industry body Nasscom and Biocon Chairperson Kiran Mazumdar Shaw on the pharma sector, Prabhu said the latter had spoken of $100 billion worth of business being achievable by the Indian pharma and biotech industry. "At the Gold Council event today ...
Read more: Growth policies being drawn up for each sector: Prabhu

Pharma Reviews: Pharmexcil to conduct interactive meeting with Cuban delegation on Dec 7 in New Delhi

The Pharmaceutical Export Promotion Council of India (Pharmexcil) is planning to conduct an interactive meeting with a high level delegation from Cuba on December 7 in New Delhi. As part of this the council is seeking participation from senior officials from the industry, government and policy makers ...
Read more: Pharmexcil to conduct interactive meeting with Cuban delegation on Dec 7 in New Delhi

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on the approval of a new formulation of buprenorphine and FDA’s efforts to promote more widespread innovation and access to opioid addiction treatments

Statement from FDA Commissioner Scott Gottlieb, M.D., on the approval of a new formulation of buprenorphine and FDA’s efforts to promote more widespread innovation and access to opioid addiction treatments
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the approval of a new formulation of buprenorphine and FDA’s efforts to promote more widespread innovation and access to opioid addiction treatments

US FDA News: FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for opioid use disorder

FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for opioid use disorder
Read more: FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for opioid use disorder

US FDA News: Statement by FDA Commissioner Scott Gottlieb, M.D., updating on Puerto Rico related medical product shortages

Statement by FDA Commissioner Scott Gottlieb, M.D. on efforts by the agency to address the impact of IV saline products and amino acids for injection shortages following the hurricane and update on FDA’s work in Puerto Rico
Read more: Statement by FDA Commissioner Scott Gottlieb, M.D., updating on Puerto Rico related medical product shortages

Pharma Reviews: Distinguished Industry Leaders Engage in a Turnkey Meeting to add Fillip to India's Pre-eminent ...

The 2nd edition of the celebrated India Pharma Week, a UBM India initiative -- introduced last year to celebrate a decade of CPhI & P-MEC, UBM's flagship engagement platform, and the world's leading Pharmaceutical networking event -- witnessed one of its most significant events, the CEO Round ...
Read more: Distinguished Industry Leaders Engage in a Turnkey Meeting to add Fillip to India's Pre-eminent ...

US FDA News: FDA announces approval, CMS proposes coverage of first breakthrough-designated test to detect extensive number of cancer biomarkers

FDA/CMS parallel review process makes test for efficient identification of multiple targeted therapy options available to health care professionals, patients and eligible Medicare beneficiaries‎ sooner
Read more: FDA announces approval, CMS proposes coverage of first breakthrough-designated test to detect extensive number of cancer biomarkers

Pharma Reviews: Virat Kohli is CNN-News18 Indian of the Year 2017

As CEO of Serum Institute, he has taken the pharma company to new heights. Nearly two-thirds of world's children are vaccinated with a Serum Institute product. Serum Institute vaccines sold at a fraction of global prices his charitable foundation supports path-breaking civic initiatives in Pune. He was ...
Read more: Virat Kohli is CNN-News18 Indian of the Year 2017

Pharma Reviews: CEO round table at Indian Pharma Week

India's pharmaceutical leaders deliberated vital issues like efforts for quality compliance, make in India in pharma sector, affordable health care and Indian pharma's supremacy at the CEO Round Table organised as a part of second edition of Indian pharma week organised by UBM in Mumbai.
Read more: CEO round table at Indian Pharma Week

Pharma Reviews: Developing on the pharma success story

The Indian pharmaceutical industry has always been at the forefront of serving the nation. From a net importer of drugs in the 1950s, today, India ...
Read more: Developing on the pharma success story

Pharma Reviews: Women in Pharma: A Path-breaking Initiative to Close in on the Gender Gap in the Burgeoning ...

The 2nd edition of the celebrated India Pharma Week, a UBM India initiative ... The percentage of women executive directors in the pharmaceutical ...
Read more: Women in Pharma: A Path-breaking Initiative to Close in on the Gender Gap in the Burgeoning ...

Pharma Reviews: CNN-News18 Indian of the Year 2017 LIVE: Virat Kohli is Indian of the Year

The year 2006 saw the introduction of the CNN-News18 Indian of the Year. ... As CEO of Serum Institute, he has taken the pharma company to new ...
Read more: CNN-News18 Indian of the Year 2017 LIVE: Virat Kohli is Indian of the Year

Pharma Reviews: Government needs proactive approach to boost pharma sector: Industry

The Indian pharmaceutical industry, with current market size of USD 27.57 billion is expected to reach USD 55 billion by 2020 growing at a CAGR of ...
Read more: Government needs proactive approach to boost pharma sector: Industry

US FDA News: Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for oral testimony before the House Committee on Energy and Commerce Hearing, “Implementing the 21st Century Cures Act: An Update from FDA and NIH"

FDA Commissioner Gottlieb provides testimony before the House Committee on Energy and Commerce on the agency’s implementation of the 21st Century Cures Act
Read more: Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for oral testimony before the House Committee on Energy and Commerce Hearing, “Implementing the 21st Century Cures Act: An Update from FDA and NIH"

Pharma Reviews: Pharma industry leaders to come out with a white paper report to be presented to policy makers

Pharma industry leaders deliberated on issues related to domestic pharma industry with focus on affordable healthcare to come out with a white paper for the policy makers on the occasion of the CEO Round Table as part of the 2nd edition of India Pharma Week, a UBM India initiative introduced to ...
Read more: Pharma industry leaders to come out with a white paper report to be presented to policy makers

Pharma Reviews: Need to overcome challenges to ensure pharma supremacy: UBM India MD

Mudras said, “Renowned as the pharmacy hub of the world, the Indian pharma economy has been lauded for its rapid growth, with a CAGR of 17.6 per cent. As we congregated for this elite knowledge-sharing session, we confronted the Indian pharma industry at a very crucial juncture in its growth ...
Read more: Need to overcome challenges to ensure pharma supremacy: UBM India MD

Pharma Reviews: Need to overcome challenges to ensure India's pharma supremacy: UBM India MD

Though India ranks amongst the top four pharmaceutical markets in terms of volume of produced drugs, certain challenges continue to plague its ...
Read more: Need to overcome challenges to ensure India's pharma supremacy: UBM India MD

Pharma Reviews: Need to overcome challenges to ensure India's pharma supremacy: UBM India MD

Though India ranks amongst the top four pharmaceutical markets in terms of volume of produced drugs, certain challenges continue to plague its pharma industry, Yogesh Mudras, managing director, UBM India, said on Wednesday. India faces issues including a time-consuming approval process, ...
Read more: Need to overcome challenges to ensure India's pharma supremacy: UBM India MD

Pharma Reviews: Healthcare's dilemma: Balancing public needs with business sense

Even the National Pharmaceutical Pricing Authority (NPPA), India's drug pricing watchdog, jumped in to demand copies of the bills, names of the ...
Read more: Healthcare's dilemma: Balancing public needs with business sense

Pharma Reviews: Government needs proactive approach to boost pharma sector: Industry

Speaking on the occasion, Indian Pharmaceutical Alliance secretary general D G Shah said, for 'Make in India', certain standards need to be set. It needs to take the initial steps and gain the confidence of the regulators and also understand that the industry culture and behavior are inter-linked.
Read more: Government needs proactive approach to boost pharma sector: Industry

Pharma Reviews: UBM organsises 'Women in Pharma' to celebrate contribution of women in pharma industry

The 2nd edition of the India Pharma Week, a UBM India initiative -- introduced last year to celebrate a decade of CPhI & P-MEC, UBM's flagship engagement platform, and the world's leading Pharmaceutical networking event -- witnessed one of its most inspiring and scintillating initiatives, 'Women in ...
Read more: UBM organsises 'Women in Pharma' to celebrate contribution of women in pharma industry

Pharma Reviews: Need to overcome challenges to ensure India's pharma supremacy: UBM India MD

... dependence on China for cheaper active pharmaceutical ingredient (API) sources, sub-optimal infrastructure, lack of funding avenues, and a shortage of highly skilled talent, among others, he said while speaking at the 2nd edition of the CEO Round Table on the sidelines of the India Pharma Week.
Read more: Need to overcome challenges to ensure India's pharma supremacy: UBM India MD

Pharma Reviews: Indian healthcare industry needs to focus on total health solutions rather than only sickness

New Delhi: The health food and dietary supplements market in India exists mostly as a part of large pharma and food companies. ... “The Indian healthcare industry needs to look at health as a whole rather than only sickness or illness in order to provide total health solutions to patients,” said Dr R B ...
Read more: Indian healthcare industry needs to focus on total health solutions rather than only sickness

Pharma Reviews: Nigeria new attraction for Indian pharma firms

ACCRA: As Indian pharma firms look to increase their footprints in Africa, Nigeria seems to be offering opportunities, as its pharmaceutical market is ...
Read more: Nigeria new attraction for Indian pharma firms

US FDA News: Biotin (Vitamin B7): Safety Communication - May Interfere with Lab Tests

Biotin in patient samples can cause falsely high or falsely low results, depending on the test. Incorrect test results may lead to inappropriate patient management or misdiagnosis.
Read more: Biotin (Vitamin B7): Safety Communication - May Interfere with Lab Tests

Pharma Reviews: Datwyler bolsters presence in India with advanced healthcare solutions for drug packing and ...

Datwyler, the Swiss-based leading industrial supplier that offers state-of-the-art solutions for drug packaging and medical devices announced that the expansion of its plant in Pune will be completed by end of 2017 and first samples will be supplied in July 2018. The facility underlines the company's ...
Read more: Datwyler bolsters presence in India with advanced healthcare solutions for drug packing and ...

Pharma Reviews: $23 billion fund sees more gains in costly Indian developers

“Indian pharma companies are building a strong product portfolio for post-2020. From a 12-18 months perspective, the sector looks good.” “We are seeing a turnaround for pharma? in India. For ?emerging markets, the big issue was currency. With the currency stabilizing, markets are growing ?at 15-20 ...
Read more: $23 billion fund sees more gains in costly Indian developers

Pharma Reviews: UBM India's CPhI and P-Mec underway in Mumbai

With a compounded annual growth of 17.6%, Indian pharma sector is expected to be worth 55 billion USD by 2020. In line with this, the life science ...
Read more: UBM India's CPhI and P-Mec underway in Mumbai

Pharma Reviews: $23 Billion Fund Sees More Gains in Costly Indian Developers

$23 Billion Fund Sees More Gains in Costly Indian Developers ... “Indian pharma companies are building a strong product portfolio for post-2020.
Read more: $23 Billion Fund Sees More Gains in Costly Indian Developers

Pharma Reviews: 11th edition of CPhI & P-MEC India gets underway in Mumbai

Speaking at the inauguration of CPhI & P-MEC India, Mr Mudras of UBM India said, "India is among the fastest-growing pharmaceutical markets in the world and has established itself as a global manufacturing and research hub. A large raw material base and the availability of a skilled workforce give the ...
Read more: 11th edition of CPhI & P-MEC India gets underway in Mumbai

Product Recall Alerts: Possible Fungal Contamination Prompts Recall of Diabetes Drug Riomet

The Food and Drug Administration (FDA) has posted a recall notification for two ... Use of contaminated product could result in infection, especially for ...
Read more: Possible Fungal Contamination Prompts Recall of Diabetes Drug Riomet

Pharma Reviews: Drug regulator to make 'stability testing' a must for all medicines sold in India

Pharma companies will now have to subject their medicines to quality tests to make sure that they do not lose their potency and the expiry dates ...
Read more: Drug regulator to make 'stability testing' a must for all medicines sold in India

Pharma Reviews: Check IPO pricing

Few listed brick-and-mortar companies are making project investments. India's information technology (IT) firms and pharma companies are under ...
Read more: Check IPO pricing

Pharma Reviews: Landmark Celebration of UBM India's 11th Edition of CPhI & P-MEC India Gets Underway Today

Originating from CPhI Worldwide, the CPhI & P-MEC India was first introduced in 2006. Today, it has become South Asia's leading pharma meeting place, covering every step of the supply chain, from drug discovery to finished dosage. CPhI India is an industry platform encompassing CROs, CMOs and ...
Read more: Landmark Celebration of UBM India's 11th Edition of CPhI & P-MEC India Gets Underway Today

US FDA News: Riomet (Metformin Hydrochloride Oral Solution): Recall - Microbial Contamination

Use of the affected product potentially could result in a risk of infection, especially in an immunocompromised patient.
Read more: Riomet (Metformin Hydrochloride Oral Solution): Recall - Microbial Contamination

Pharma Reviews: Indian Pharma run rate slows down in Q2 2018

Majority of Indian pharmaceutical companies have reported disappointing results in Q2 of FY 2018 compared to the same period last year. Financial analysts believe the sharp drop in pharma margins are due to regulatory and pricing challenges in the U.S market in addition to the changes created by ...
Read more: Indian Pharma run rate slows down in Q2 2018

Pharma Reviews: Uzbekistan invites Indian pharma industries to come and Make in Uzbek

New Delhi, Nov 27 (KNN) In a bid to attract investments from India, Uzbekistan urged the Indian pharma industry comprising of a fair share of Micro, ...
Read more: Uzbekistan invites Indian pharma industries to come and Make in Uzbek

Pharma Reviews: Indian pharma plans new set-up in Cambodia

India-based pharmaceutical company, VTSIX Group, will soon be setting up a factory in Cambodia in early 2018 after signing a land lease agreement ...
Read more: Indian pharma plans new set-up in Cambodia

Pharma Reviews: Stocks To Watch: Ashok Leyland, Hindustan Unilever, Sun Pharma

Indian equity benchmarks closed little changed after fluctuating intraday on ... Sun Pharmaceutical Industries to recall Riomet drug due to microbial ...
Read more: Stocks To Watch: Ashok Leyland, Hindustan Unilever, Sun Pharma

Pharma Jobs: Area Sales Manager

Company: Kuresys Labs Private Limited
Qualification: Any graduate
Experience: 2 to 5
location: Delhi, Noida
Ref: 21569069
Summary: Looking for Area Sales Manager Pharma for Delhi, Greater Noida & Noida Region Salary Range : INR 3,00,000 - 5,50,000 P.A

Read more: Area Sales Manager

Pharma Reviews: SCHOTT KAISHA to showcase innovative range of packaging solutions at CPhI India 2017

The Indian pharma packaging leader will also be showcasing its enhanced portfolio of ready-to-use (RTU) packaging, which now includes nested cartridges. As the range of nested solutions has made pharmaceutical manufacturing lines more efficient, the new system will give pharma manufacturers a ...
Read more: SCHOTT KAISHA to showcase innovative range of packaging solutions at CPhI India 2017

Pharma Reviews: Sun Pharma recalls two lots of diabetes drug due to microbial contamination

New Delhi: Indian drug major Sun Pharma's subsidiary in the US is ... Sun Pharmaceutical Industries, Inc (SPII), Sun Pharma's wholly owned ...
Read more: Sun Pharma recalls two lots of diabetes drug due to microbial contamination

Pharma Reviews: WHO to hold consultation on Survey of Indian Pharma Enterprises for Meeting National & Global ...

World Health Organization (WHO) is planning to analyze the performances of Indian pharmaceutical industry and the international laws for trade and ...
Read more: WHO to hold consultation on Survey of Indian Pharma Enterprises for Meeting National & Global ...

Pharma Reviews: Uzbekistan invites Indian cos to invest in its 7 new free economic zones for pharma

Uzbekistan, which is a leading country from the Commonwealth Independent states (CIS) region, has invited Indian pharmaceutical manufacturers to ...
Read more: Uzbekistan invites Indian cos to invest in its 7 new free economic zones for pharma

Pharma Reviews: Brinton Pharma eyes second round of funding to finance growth

Brinton Pharma eyes second round of funding to finance growth ... A report by Deloitte Touche Tohmatsu India indicates the size of the industry will reach USD 280 billion by 2020 from the present USD 160 billion. PTI AP BEN BEN . This is unedited, unformatted feed from the Press Trust of India wire.
Read more: Brinton Pharma eyes second round of funding to finance growth

Pharma Reviews: Everstone Group acquires Malaysian medical products company Chemopharm

The Everstone Group has significant experience in the healthcare sector. Similar to Everlife, Everstone has also invested in Ascent, the leading Indian pharma distribution platform, which has scaled rapidly under Everstone's ownership. Other Everstone investments in healthcare are Rubicon, ...
Read more: Everstone Group acquires Malaysian medical products company Chemopharm

Pharma Reviews: Systech, NKP Pharma ink agreement to deliver pharmaceutical serialization & traceability solutions ...

"Regionally specific serialization regulations are rapidly rolling out and Indian pharma must meet them to ensure full compliance in order to continue serving a global market," said Harry Saint-Preux, director - Global Alliances & Channels. "Our partnership with NKP allows for simplified regulatory ...
Read more: Systech, NKP Pharma ink agreement to deliver pharmaceutical serialization & traceability solutions ...

Pharma Reviews: Leading Indian drug makers evince interest in setting up units in RAKEZ, UAE

Around 8-10 leading pharmaceutical companies from India have evinced interest in setting up their units and facilities in Ras Al Khaimah Economic ...
Read more: Leading Indian drug makers evince interest in setting up units in RAKEZ, UAE

Pharma Reviews: Govt plans tweaks in law to make firms liable for defective devices, drugs

The Central Drug Standards Control Organization (CDSCO), the national regulatory body for Indian pharmaceutical and medical device makers, has ...
Read more: Govt plans tweaks in law to make firms liable for defective devices, drugs

Pharma Reviews: Innovations to Scale-up Healthcare Industry

A good example of which is many Indian Pharma companies are selling their drugs in the western world at much economical rates and with an ...
Read more: Innovations to Scale-up Healthcare Industry

US FDA News: FDA approves first implanted lens that can be adjusted after cataract surgery to improve vision without eyeglasses in some patients

FDA approved the RxSight Inc. Light Adjustable Lens and Light Delivery Device, the first medical device system that can make small adjustments to the artificial lens’ power after cataract surgery so that the patient will have better vision when not using glasses.
Read more: FDA approves first implanted lens that can be adjusted after cataract surgery to improve vision without eyeglasses in some patients

Pharma Reviews: Thermo Fisher calls for multi-pronged approach to tackle menace of counterfeit products

According to the Indian Journal of Pharmaceutical Sciences' research study that ... Thermo Fisher Scientific, with its in-depth pharmaceutical industry ...
Read more: Thermo Fisher calls for multi-pronged approach to tackle menace of counterfeit products

Pharma Reviews: Systech International and NKP Pharma Expand Presence in India to Deliver Pharmaceutical ...

The accord allows the two companies to provide software/hardware solutions to the Indian pharmaceutical industry that meet serialization and ...
Read more: Systech International and NKP Pharma Expand Presence in India to Deliver Pharmaceutical ...

Pharma Reviews: Pharma stocks outperform, Nifty ends the session marginally higher

Pharma stocks outperform, Nifty ends the session marginally higher ... Call Registry” as laid down by “Telecom Regulatory Authority of India” will not be ... Support levels for the market inched higher with 10300PE witnessing heavy ...
Read more: Pharma stocks outperform, Nifty ends the session marginally higher

US FDA News: FDA approves first two-drug regimen for certain patients with HIV

FDA approved Juluca, the first complete treatment regimen containing only two drugs to treat certain adults with human immunodeficiency virus type 1 (HIV-1) instead of three or more drugs included in standard HIV treatment.
Read more: FDA approves first two-drug regimen for certain patients with HIV

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on steps to promote development of generic versions of opioids formulated to deter abuse

FDA Commissioner on steps to promote development of generic versions of opioids formulated to deter abuse
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on steps to promote development of generic versions of opioids formulated to deter abuse

US FDA News: Limbrel Capsules by Primus Pharmaceuticals: FDA Advisory - Linked to Potentially Life-Threatening Health Problems

Anyone who is currently taking Limbrel may be at risk for developing symptoms associated with drug-induced liver injury and/or hypersensitivity pneumonitis. Posted 11/21/2017
Read more: Limbrel Capsules by Primus Pharmaceuticals: FDA Advisory - Linked to Potentially Life-Threatening Health Problems

Pharma Reviews: Nadda for more investment, players in medical devices sector

The Union health minister said India is deeply committed, both nationally and globally, for achieving all public health goals and was also focusing on ... Highlighting the importance of transparency between regulatory authorities and pharma sector, he said coordination between national regulatory ...
Read more: Nadda for more investment, players in medical devices sector

Pharma Reviews: The 'India Pharma Week' Returns With a Week Full of Avant-garde Events Alongside CPhI and P ...

An epitome of India's strength in the pharma industry, the expo has consistently grown to serve as an exclusive congregation of key global players across the pharmaceutical sector. Over the past few years, India is seen as a potential market for global pharmaceutical manufacturers and is now ready to ...
Read more: The 'India Pharma Week' Returns With a Week Full of Avant-garde Events Alongside CPhI and P ...

Pharma Reviews: Pharma firms tide over GST impact

Pharma industry players say that during April to June period, several pharma ... "The Indian pharmaceutical market's growth had eased to around 3%, ...
Read more: Pharma firms tide over GST impact

Pharma Reviews: Banning combination drugs: A high-stakes case in point

Except the problem in India is that the pharmaceutical industry has turned to FDCs to escape price control. Back in the day when Drug Price Control Orders established prices of drugs with single ingredients, the pharmaceutical industry decided to combine different drugs into a FDC, thereby creating a ...
Read more: Banning combination drugs: A high-stakes case in point

Pharma Reviews: Adverse observations on domestic facilities: Tackling the USFDA regulatory heat

The Indian Express has reviewed the detailed responses sent by two Indian drug manufacturers, Strides Shasun for its Bengaluru (Anekal Taluk) facility and Cadila Healthcare for its Matoda (Sanand) facility on the USFDA observations, following which the US regulator has accorded clearances to these ...
Read more: Adverse observations on domestic facilities: Tackling the USFDA regulatory heat

Pharma Reviews: CPhI India 2017 to take place at two venues in Mumbai

CPhI India 2017, India's largest and leading pharmaceutical exhibition will be taking place at two venues in Mumbai - the Bombay Convention and Exhibition Centre (BCEC) and the MMRDA Grounds, Bandra Kurla Complex (BKC).While BCEC will host it between November 28 and 30, BKC will kick off ...
Read more: CPhI India 2017 to take place at two venues in Mumbai

Pharma Reviews: We expect big numbers to kick in from FY20-FY21: Kiran Mazumdar Shaw, Biocon

The signalling should be that Biocon has complied with all USFDA problems and unlike other Indian pharma companies, decks are cleared for Biocon ...
Read more: We expect big numbers to kick in from FY20-FY21: Kiran Mazumdar Shaw, Biocon

Pharma Reviews: Chinese investors keen on infra projects in India

Chinese investors keen on infra projects in India ... Agriculture and Food Processing Sector and Bio-Technology and Pharma Industry; Infrastructure, ...
Read more: Chinese investors keen on infra projects in India

Pharma Reviews: The Red In That Green

Since that 2013 judgement, the US and UK have tried to get Indian laws diluted. “MNCs perceived a threat from the steady growth of Indian pharma companies before 2005,” says James. “So, several attempts were made to tweak laws in their favour.” The US even had India put on the “priority watchlist” ...
Read more: The Red In That Green

US FDA News: FDA approves first telehealth option to program cochlear implants remotely

FDA approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System through a telemedicine platform.
Read more: FDA approves first telehealth option to program cochlear implants remotely

Pharma Reviews: Eris Life to acquire Strides' India business for Rs 500 crore

MUMBAI: Bengaluru-based drug maker Strides Shasun has agreed to sell its domestic branded formulations business to Ahmedabad-based Eris Lifesciences for Rs 500 crore, joining a select league of Indian pharmaceuticals firms exiting domestic market to focus on more lucrative international ...
Read more: Eris Life to acquire Strides' India business for Rs 500 crore

US FDA News: Diphenoxylate Hydrochloride and Atropine Sulfate Tablets by Greenstone: Recall - Possible Sub Potent and Super Potent Tablets

The use of this product in patients with uncontrolled diarrhea due to chronic medical conditions may predispose the patient to toxicity from either the diphenoxylate or atropine components. Posted 11/17/2017
Read more: Diphenoxylate Hydrochloride and Atropine Sulfate Tablets by Greenstone: Recall - Possible Sub Potent and Super Potent Tablets

US FDA News: Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts to address impact of IV fluid shortages following hurricane destruction and resolve manufacturing shortfalls

Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts by the agency to address impact of IV fluid shortages following hurricane destruction and resolve manufacturing shortfalls
Read more: Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts to address impact of IV fluid shortages following hurricane destruction and resolve manufacturing shortfalls

Pharma Reviews: Gujarat elections: Pharma sector eyes GST boost, thanks BJP govt for infra push

“Brand Gujarat has been in high demand all over India, specially for the pharma sector, given the fact that Gujarat produces the highest quality of ...
Read more: Gujarat elections: Pharma sector eyes GST boost, thanks BJP govt for infra push

Pharma Reviews: Two hundred pharma personnel in TN & Pondicherry were trained by IPC in setting up PV system

... pharmacovigilance (PV) system to become a mandatory in-house mechanism for all pharmaceutical manufacturing units, the Indian Pharmacopoeia ...
Read more: Two hundred pharma personnel in TN & Pondicherry were trained by IPC in setting up PV system

US FDA News: FDA expands approval of Sutent to reduce the risk of kidney cancer returning

FDA approves first adjuvant treatment for adult patients who are at a high risk of kidney cancer returning after a kidney has been removed.
Read more: FDA expands approval of Sutent to reduce the risk of kidney cancer returning

US FDA News: FDA approves new treatment to prevent bleeding in certain patients with hemophilia A

FDA approves new treatment to prevent or reduce frequency of bleeding episodes in patients with hemophilia A who have Factor VIII inhibitors.
Read more: FDA approves new treatment to prevent bleeding in certain patients with hemophilia A

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA’s comprehensive new policy approach to facilitating the development of innovative regenerative medicine products to improve human health

Commissioner statement on FDA’s comprehensive regenerative medicine policy framework to spur innovation, efficient access to potentially transformative products, while ensuring safety and efficacy
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA’s comprehensive new policy approach to facilitating the development of innovative regenerative medicine products to improve human health

US FDA News: FDA announces comprehensive regenerative medicine policy framework

FDA announces comprehensive regenerative medicine policy framework to spur innovation, efficient access to potentially transformative products, while ensuring safety and efficacy.
Read more: FDA announces comprehensive regenerative medicine policy framework

Pharma Reviews: To pay back ONGC Videsh, Venezuela's PDUSA offers oil in lieu of cash

India's exports to Venezuela fell from $258 million in 2014-15 to just $62.22 million in the last financial year, mostly on account of pharmaceutical ...
Read more: To pay back ONGC Videsh, Venezuela's PDUSA offers oil in lieu of cash

Pharma Reviews: Pharma growth to pick up in 2nd half

Expectations of a gradual reduction in pricing pressure in the US market were belied as Indian pharmaceutical companies reported another quarter of ...
Read more: Pharma growth to pick up in 2nd half

US FDA News: FDA unveils a streamlined path for the authorization of tumor profiling tests alongside its latest product action

Newly authorized test detects genetic cancer mutations in 468 unique genes
Read more: FDA unveils a streamlined path for the authorization of tumor profiling tests alongside its latest product action

US FDA News: Nexterone (amiodarone HCl) 150 mg/100 mL Premixed Injection: Recall - Presence Of Particulate Matter

Intravenous administration of a solution containing sterile particulate matter may lead to adverse health consequences.
Read more: Nexterone (amiodarone HCl) 150 mg/100 mL Premixed Injection: Recall - Presence Of Particulate Matter

US FDA News: FDA approves treatment for rare genetic enzyme disorder

FDA approves treatment for rare genetic enzyme disorder
Read more: FDA approves treatment for rare genetic enzyme disorder

Pharma Reviews: Imports To Fuel India's Active Pharmaceutical Ingredients' Requirements

India Ratings and Research expects India to remain dependent on imports for its Active Pharmaceutical Ingredients (API) requirements at least in the ...
Read more: Imports To Fuel India's Active Pharmaceutical Ingredients' Requirements

US FDA News: Febuxostat (Brand Name Uloric): Drug Safety Communication - FDA to Evaluate Increased Risk of Heart-related Death

Preliminary safety trial results in over 6,000 patients with gout being evaluated.
Read more: Febuxostat (Brand Name Uloric): Drug Safety Communication - FDA to Evaluate Increased Risk of Heart-related Death

US FDA News: FDA grants marketing authorization of the first device for use in helping to reduce the symptoms of opioid withdrawal

FDA permits marketing of the first device for use in helping to reduce the symptoms of opioid withdrawal
Read more: FDA grants marketing authorization of the first device for use in helping to reduce the symptoms of opioid withdrawal

US FDA News: FDA warns about illegal use of injectable silicone for body contouring and associated health risks

FDA issues safety communication about illegal use of injectable silicone for body contouring and associated health risks
Read more: FDA warns about illegal use of injectable silicone for body contouring and associated health risks

US FDA News: Injectable Silicone for Body Contouring and Enhancement: FDA Safety Communication - FDA Warns Against Use

Silicone, when injected into areas with many blood vessels, can travel to other parts of the body and block blood vessels in the lungs, heart, or brain. This can result in permanent damage to those tissues and lead to stroke or death.
Read more: Injectable Silicone for Body Contouring and Enhancement: FDA Safety Communication - FDA Warns Against Use

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA advisory about deadly risks associated with kratom

A botanical substance known as kratom has raised significant concerns given its increasing prevalence and potential safety risks. The FDA has issued a public health advisory related to mounting concerns regarding risks associated with the use of kratom.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. on FDA advisory about deadly risks associated with kratom

Pharma Reviews: Call for 'complete' overhaul of India's CSIR

CSIR is the country's largest public sector research and development ... to development of Indian pharma and chemical companies during 1980s and ...
Read more: Call for 'complete' overhaul of India's CSIR

Pharma Reviews: Roche appoints Lara Bezerra as Roche Pharma India MD

Roche Pharmaceutical Asia Pacific Region head Christiane Hamacher said: "We are delighted to have Lara Bezerra join Roche India from Venezuela.
Read more: Roche appoints Lara Bezerra as Roche Pharma India MD

Pharma Reviews: Assam strides towards flourishing economic and social advancement

The Indian Pharmaceutical Market which has a global reputation of selling high quality, low cost drugs, can leverage this by welcoming more and ...
Read more: Assam strides towards flourishing economic and social advancement

Pharma Reviews: Indian Pharmaceutical Alliance pitches for exception of GST on expired and damaged drugs

The Indian Pharmaceutical Alliance has been pitching with the government to exempt Goods and Services Tax (GST) on drugs that are expired or ...
Read more: Indian Pharmaceutical Alliance pitches for exception of GST on expired and damaged drugs

US FDA News: FDA approves pill with sensor that digitally tracks if patients have ingested their medication

The U.S. Food and Drug Administration today approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and for use as an add-on treatment for depression in adults.
Read more: FDA approves pill with sensor that digitally tracks if patients have ingested their medication

Pharma Reviews: Sale of diabetes drug rise from 151 crore to 842 crore in 9 years: Study

Indiscriminate use of newer oral drugs and insulin is often seen in India and here, ... India has to take several stringent measures to ensure that there is a ... were tracked every month from pharmaceutical stockists and distributors.
Read more: Sale of diabetes drug rise from 151 crore to 842 crore in 9 years: Study

Pharma Reviews: Gujarat set to give China stiff competition in hormone APIs

Ahmedabad: Gujarat could potentially breach China a virtual monopoly in catering to India's $400 million hormonal active pharmaceutical ingredient ...
Read more: Gujarat set to give China stiff competition in hormone APIs

Pharma Reviews: Rakesh Jhunjhunwala says make at least this much return in stock market or go home

I see no way in which Indian equities will give anything below 15%.” ... Last month during Diwali, Rakesh Jhunjhunwala said that pharma industry is ...
Read more: Rakesh Jhunjhunwala says make at least this much return in stock market or go home

Pharma Reviews: Fresh salvo in the turf battle between innovator & generic drug makers

Some of the senior officials and business leaders from the Indian pharmaceutical companies also complained about this though none of them wanted ...
Read more: Fresh salvo in the turf battle between innovator & generic drug makers

Pharma Jobs: Pharma Pharmacist walk in Interview 13 November 2017 to 25 November 2017

Company: Ace Group
Experience: 0 to 5
location: Mumbai
Ref: 21513000
Summary: Pharma , D phama , b pharma , Bsc Msc , B.Tech Are any degree . Candidate should have knowledge of pharma.Chemical , Food with good knowledge of communication skills, Innovate bent of mind, Analytical and Problem solving skills fresher and exp

Read more: Pharma Pharmacist walk in Interview 13 November 2017 to 25 November 2017

Pharma Jobs: Pharma Pharmacist walk in Interview 13 November 2017 to 25 November 2017

Company: Ace Group
Experience: 0 to 5
location: Pune
Ref: 21513005
Summary: Pharma , D phama , b pharma , Bsc Msc , B.Tech Are any degree . Candidate should have knowledge of pharma.Chemical , Food with good knowledge of communication skills, Innovate bent of mind, Analytical and Problem solving skills fresher and exp

Read more: Pharma Pharmacist walk in Interview 13 November 2017 to 25 November 2017

Pharma Jobs: Pharma Pharmacist walk in Interview 13 November 2017 to 25 November 2017

Company: Ace Group
Experience: 0 to 5
location: Bengaluru / Bangalore
Ref: 21513008
Summary: Pharma , D phama , b pharma , Bsc Msc , B.Tech Are any degree . Candidate should have knowledge of pharma.Chemical , Food with good knowledge of communication skills, Innovate bent of mind, Analytical and Problem solving skills fresher ....
Read more: Pharma Pharmacist walk in Interview 13 November 2017 to 25 November 2017

Pharma Jobs: Biotechnology walk in Interview 13 November 2017 to 25 November 2017

Company: Ace Group
Experience: 0 to 5
location: Bengaluru / Bangalore
Ref: 21513051
Summary: Biotechnology ,Bsc Msc , B.Tech Are any degree . Candidate should have knowledge of pharma.Chemical , Food with good knowledge of communication skills, Innovate bent of mind, Analytical and Problem solving skills fresher and exp

Read more: Biotechnology walk in Interview 13 November 2017 to 25 November 2017

Pharma Reviews: Putting the spotlight back on domestic consolidation

The Indian pharmaceutical space has long been waiting for consolidation, Torrent Pharmaceuticals Chairman Samir Mehta had told BusinessLine's ...
Read more: Putting the spotlight back on domestic consolidation

Pharma Reviews: UBM India Brings in the 12th Edition of Food Ingredients India & Health Ingredients in Mumbai

UBM has a strong foothold in key industry segments like Food, Pharma and Cosmetics. Packaging being the most integral part of these industries, the ...
Read more: UBM India Brings in the 12th Edition of Food Ingredients India & Health Ingredients in Mumbai

US FDA News: Compounded Glutamine, Arginine, and Carnitine Product for Injection by United Pharmacy: Compounding Risk Alert - FDA Investigates Two Adverse Events

Parenteral drugs, including compounded injectable drugs, with a high pH may lead to skin damage or other unintended health consequences.
Read more: Compounded Glutamine, Arginine, and Carnitine Product for Injection by United Pharmacy: Compounding Risk Alert - FDA Investigates Two Adverse Events

Pharma Reviews: Morepen inks pact with Vésale Pharma to boost presence in Rs 1000-crore probiotics market

NEW DELHI: Indian pharmaceutical firm Morepen Laboratories Ltd, listed on the Bombay Stock Exchange, has inked an exclusive agreement to ...
Read more: Morepen inks pact with Vésale Pharma to boost presence in Rs 1000-crore probiotics market

Pharma Reviews: Companies cut hiring costs with in-house cells

Sun Pharmaceutical Industries (Sun Pharma), Philips India and Johnson & Johnson (J&J) have already built in-house capabilities to hire executives.
Read more: Companies cut hiring costs with in-house cells

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. on new steps to improve FDA review of shared Risk Evaluation and Mitigation Strategies to improve generic drug access

To further streamline the submission and review process for shared system REMS (for any REMS that includes more than one medication), today the FDA is releasing a draft guidance for industry, Use of a Drug Master File for Shared System REMS Submissions, that describes how applicants can submit collective sets of files to the FDA that represent all participating firms.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. on new steps to improve FDA review of shared Risk Evaluation and Mitigation Strategies to improve generic drug access

Pharma Reviews: Gujarat takes lead to resolve pending cases on food adulteration

Deepnath Roy Chowdhury, National President, Indian Drug Manufacturers' Association (IDMA), pointed out some regulatory challenges in the current ...
Read more: Gujarat takes lead to resolve pending cases on food adulteration

Pharma Reviews: Pharma sector raises demand of GST exemption on expired and damaged medicines

Indian Pharmaceutical Alliance (IPA) in a statement said that the exemption of GST on expired and damaged stock of medicines is vital to prevent ...
Read more: Pharma sector raises demand of GST exemption on expired and damaged medicines

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on a practical approach to ensuring timely implementation of FDA’s menu labeling rule

FDA menu labeling guidance
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on a practical approach to ensuring timely implementation of FDA’s menu labeling rule

Pharma Reviews: Rising crude prices behind markets taking breather: Pankaj Tibrewal, Kotak Mutual Fund

Talking to ET Now, Pankaj Tibrewal , SVP & Fund Manager-Equities, Kotak Mutual Fund , says the tailwinds which we enjoyed on the macro for the ...
Read more: Rising crude prices behind markets taking breather: Pankaj Tibrewal, Kotak Mutual Fund

Pharma Reviews: Will continue to pursue inorganic growth in India & US: Torrent Pharma

Mehta said that Torrent will become fifth largest company in India, with ... According to him, Indian pharma market is large and therefore, he expects ...
Read more: Will continue to pursue inorganic growth in India & US: Torrent Pharma

Pharma Reviews: Pharma cos need to find chemical attractants to fight menace of mosquito-borne diseases. Dr Biju ...

In the wake of increasing number of mosquito borne diseases and high mortality rates happening every year, the pharmaceutical industry in India ...
Read more: Pharma cos need to find chemical attractants to fight menace of mosquito-borne diseases. Dr Biju ...

US FDA News: FDA clears common blood cell count test that offers faster results for patients and providers

The U.S. Food and Drug Administration today cleared a complete blood cell count (CBC) test that, based on its categorization, can be run in more health care settings, including physicians’ offices, clinics or other types of health care facilities, by a wider range of personnel (e.g. support staff). This broadened test access will allow for faster availability of results.
Read more: FDA clears common blood cell count test that offers faster results for patients and providers

Pharma Reviews: Indian pharma majors under investigation for multistate antitrust scheme

The fate of seven Indian pharmaceutical companies functioning in the US stays hanging as Connecticut Attorney General George Jepsen along with ...
Read more: Indian pharma majors under investigation for multistate antitrust scheme

Pharma Reviews: GST on expired and damaged stocks costs pharma Rs 500 crore a year

Why should there be the Goods and Services Tax (GST) on materials that cannot be sold? That is the question, the Indian pharmaceutical industry, ...
Read more: GST on expired and damaged stocks costs pharma Rs 500 crore a year

Pharma Reviews: ET Analysis: With Unichem Buy, Torrent's new M&A star in pharma

However, what the deal underscores is the rise of Ahmedabadbased Torrent Pharma as another Indian pharma firm being successful at its M&A game ...
Read more: ET Analysis: With Unichem Buy, Torrent's new M&A star in pharma

US FDA News: FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer

FDA expands approval of Zelboraf (vemurafenib) to include treatment of certain adult patients with Erdheim-Chester Disease, a rare blood cancer. This is the first FDA-approved treatment for ECD.
Read more: FDA approves first treatment for certain patients with Erdheim-Chester Disease, a rare blood cancer

US FDA News: Infant/Child Reduced Energy Defibrillation Electrodes by Cardinal Health: Voluntary Field Action - Incorrect Artwork on Packaging

If the user incorrectly places the defibrillation electrodes, it may result in ineffective energy delivery to the patient and serious injury or death.
Read more: Infant/Child Reduced Energy Defibrillation Electrodes by Cardinal Health: Voluntary Field Action - Incorrect Artwork on Packaging

US FDA News: Ridge Properties DBA Pain Relief Naturally Products: Recall - Manufacturing Concerns at the Facility

Risk of decreased quality and consistency (i.e., the safety, identity, strength, quality and purity)
Read more: Ridge Properties DBA Pain Relief Naturally Products: Recall - Manufacturing Concerns at the Facility

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on implementation of agency’s streamlined development and review pathway for consumer tests that evaluate genetic health risks

Statement from FDA Commissioner Scott Gottlieb, M.D., on implementation of agency’s streamlined development and review pathway for consumer tests that evaluate genetic health risks
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on implementation of agency’s streamlined development and review pathway for consumer tests that evaluate genetic health risks